Social Media Sidebar

Announcement

Please sign up, comment on articles and bring your friends!

Current poll

PlanetTech is asking:

What do you think about our new web site?

Love it, indeed
Really good solution
Same as old one
The old one was better
This is a new option

Quote of the day

When seen through the lens of technology, few resources are truly scarce; they’re mainly inaccessible. 

 

Peter Diamandis

Tumor-killing virus nearly doubles survival time of brain cancer patients

RATE THIS! +42
Posted in Science on 5th Jun, 2016 06:58 PM by AlexMuller

To defeat the deadliest of cancers, it's time to unleash the viruses. In a small clinical trial with brain cancer patients, a tumor-seeking virus successfully invaded cancer cells and smuggled in molecular detonators, allowing doctors to selectively blast the deadly growths with a toxic drug.

 

In the trial’s 45 participants, who were fighting the most aggressive forms of brain cancer known, the virus-drug combo nearly doubled their average survival time while showing no dangerous side effects. The finding, published Wednesday in the journal Science Translational Medicine, demonstrates the utility of such viruses and also provides a green light for the treatment strategy to move on to more trials.

 
These brain cancers usually have few treatment options and lead to “dismal clinical outcomes,” the authors wrote. However, this new viral therapy has “the potential to fill this medical need,” they concluded.
 
Ars has reported on cancer-killing viruses before, but this new virus works a little differently. Instead of directly killing a cancer cell, the virus lays the groundwork for targeted drug strikes.
 
The virus, dubbed Toca 511, specifically seeks out and invades cancer cells with broken defense systems that would normally block the viral invasion. Once inside, the virus slips the genetic blueprints for an enzyme into the cells’ DNA. The cancer cell then unwittingly reads through the blueprints and produces the enzyme, the yeast cytosine deaminase (CD), which acts as a drug detonator.
 
In the second part of the treatment, doctors send in the chemical bomb: an inactive form of a cancer drug called 5-FU, or 5-fluorouracil. This drug is highly effective at killing cancer cells, but it’s also highly toxic and generally unsafe to inject straight up into patients. With the inactive molecule, delivered either directly into the brain or intravenously, a tame version can safely roam around until it reaches the tumor. There, the CD enzyme lying in wait transforms it into an active cancer killer.
 
For the trial, researchers enrolled patients with some of the deadliest forms of recurring brain cancer, called high-grade gliomas. In a control group that was part of another study on the same types of cancers, patients lived for a mean of 7.1 months after the first or second recurrence and had brain surgery to remove tumor masses. Patients that received Toca 511 and the tame version of 5-FU after brain surgery survived for a mean of 13.6 months.
 
Those virus-treated patients had no major side effects from the virus or toxicity from 5-FU. When the researchers scanned the patients' blood after the treatments, they found that the virus was no longer detectable, but it could be found around brain tumors. This suggests that the virus was indeed selectively invading tumor cells.
 
While the results are promising, the study is only a phase I trial, and the treatment needs to be tested out in bigger groups of patients with more controls. The authors report that phase II trials are now in progress.

Tags: viruscanceroncologyneurosciencebraintumorhealthresearchmedicine

Read original article » Back to category

Comments

Author: Guest
Posted: 2016-06-06
+1
Very interesting and elaborate protocol! What is particularly important is that the virus-treated patients had no major side effects from the virus or toxicity from 5-FU. Reply
Author: Guest
Posted: 2016-06-06
+0
The application to brain tumours is particularly important. These brain cancers usually have few treatment options and lead to dismal clinical outcomes. Reply


 

Recent headlines

  • Posted in Medicine on 2017-11-21 09:01:15
    High Incidence of PTSD Among Cancer Patients..read more
    Posted in Science on 2017-11-21 08:56:02
    Human Memory Enhanced With a Brain Implant For the First.....read more
    Posted in Hardware on 2017-11-21 08:51:13
    MIT Reveals a Battery That Stores Solar Energy to Make.....read more
    Posted in Science on 2017-11-21 08:45:29
    Japan discovers new 50km cave in moon, raises hope for.....read more
    Posted in Software on 2017-11-20 17:24:02
    The 3 biggest threats to your Bitcoin (and 10 tips to.....read more
Posted in Business on 2013-10-10 01:33
China is working towards a manned lunar mission in about.....read more
Posted in Business on 2013-10-20 07:17
Spacex says China is their main competitor for commercial.....read more
Posted in Software on 2013-10-20 06:43
Pirate Bay Browser Clocks 1,000,000 Downloads..read more
Posted in Medicine on 2013-10-10 02:10
Google reportedly investing hundreds of millions into new.....read more
Posted in Medicine on 2013-10-14 03:13
Endothelial Cells Can Repair and Regenerate Organs,.....read more
Posted in Science on 01.01.2010
Spacex says China is their main competitor for commercial.....read more
Posted in Science on 01.01.2010
Staring at Your Phone Could Be Making You Short Sighted..read more
Posted in Science on 01.01.2010
Oculus Rift virtual reality headset coming to mobile, but.....read more
Posted in Science on 01.01.2010
China is working towards a manned lunar mission in about.....read more
Posted in Science on 01.01.2010
Delivering drugs via nanoparticles to target mitochondria..read more

Recent Blog Posts

  • Posted by AlexMuller
    Martian landscapes formed from sand 'levitating' on a little.....read more
    Posted by AlexMuller
    Scientists detect comets outside our solar system..read more
    Posted by AlexMuller
    Advanced artificial limbs mapped in the brain..read more
    Posted by AlexMuller
    Bacteria have a sense of touch..read more
    Posted by AlexMuller
    Recurrent brain cancer: New hope with phase 1 clinical trial.....read more

Login to your Account

Login to your PlanetTech Account here

Username:
Password:
Remember me
or

Create a New Account

You just need username and password

The following errors occured:
Username:
Email:
Password:
Verify password:
Remember me